TARDBP and Alzheimer disease: Similar to LBD, the presence of TDP-43 in the setting of AD has been noted to enhance cognitive impairment, represented by reduced scores on cognitive function tests, as well as increased likelihood of developing AD-like symptoms before death (80, 86, 121).